Novartis Pipeline Strengthening Efforts
Novartis is actively pursuing strategic deals to enhance its pipeline. The company’s CEO, Vas Narasimhan, has stated the intention to fill pipeline gaps through smaller acquisitions.
Acquisition Strategy
The company aims to acquire assets with readouts scheduled between 2027 and 2030 to regain market confidence. This move is in response to patent expirations of several key drugs by the end of the decade.
Market Expansion
Novartis is also exploring opportunities in the weight loss treatment market. The company is seeking a next-generation obesity therapy that can differentiate itself from existing treatments.
Key Objectives
- Fill pipeline gaps through strategic acquisitions
- Acquire assets with readouts between 2027 and 2030
- Regain market confidence
- Explore opportunities in the weight loss treatment market
- Develop a next-generation obesity therapy